Login / Signup

Evaluation of a pharmacokinetic-pharmacodynamic model for hypouricaemic effects of febuxostat using datasets obtained from real-world patients.

Toshinori HiraiToshimasa ItohToshimi KimuraHirotoshi Echizen
Published in: British journal of clinical pharmacology (2018)
The PK-PD model may be useful for predicting individualized maintenance doses of febuxostat in real-world patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • single cell